Derivation and Clinical Utility of Safety Targets for Linezolid-Related Adverse Events in Drug-Resistant Tuberculosis Treatment.
Pharmaceuticals (Basel)
; 16(11)2023 Nov 08.
Article
em En
| MEDLINE
| ID: mdl-38004440
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article